87 related articles for article (PubMed ID: 2465504)
1. Galanin immunoreactivity in human CSF: studies in eating disorders and Alzheimer's disease.
Berrettini WH; Kaye WH; Sunderland T; May C; Gwirtsman HE; Mellow A; Albright A
Neuropsychobiology; 1988; 19(2):64-8. PubMed ID: 2465504
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid peptide YY immunoreactivity in eating disorders.
Berrettini WH; Kaye WH; Gwirtsman H; Allbright A
Neuropsychobiology; 1988; 19(3):121-4. PubMed ID: 3200408
[TBL] [Abstract][Full Text] [Related]
3. Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome.
Nemeroff CB; Bissette G; Widerlov E; Beckmann H; Gerner R; Manberg PJ; Lindstrom L; Prange AJ; Gattaz WF
J Neuropsychiatry Clin Neurosci; 1989; 1(1):16-20. PubMed ID: 2577718
[TBL] [Abstract][Full Text] [Related]
4. Measurement of CSF dynorphin A 1-8 immunoreactivity in anorexia nervosa and normal-weight bulimia.
Lesem MD; Berrettini WH; Kaye WH; Jimerson DC
Biol Psychiatry; 1991 Feb; 29(3):244-52. PubMed ID: 1673064
[TBL] [Abstract][Full Text] [Related]
5. Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa.
Kaye WH; Berrettini W; Gwirtsman H; George DT
Arch Gen Psychiatry; 1990 Jun; 47(6):548-56. PubMed ID: 2350207
[TBL] [Abstract][Full Text] [Related]
6. Galanin-like immunoreactivity is increased in the postmortem cerebral cortex from patients with Alzheimer's disease.
Gabriel SM; Bierer LM; Davidson M; Purohit DP; Perl DP; Harotunian V
J Neurochem; 1994 Apr; 62(4):1516-23. PubMed ID: 7510783
[TBL] [Abstract][Full Text] [Related]
7. CSF oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiologic considerations.
Demitrack MA; Lesem MD; Listwak SJ; Brandt HA; Jimerson DC; Gold PW
Am J Psychiatry; 1990 Jul; 147(7):882-6. PubMed ID: 2356873
[TBL] [Abstract][Full Text] [Related]
8. Could reduced cerebrospinal fluid (csf) galanin contribute to restricted eating in anorexia nervosa?
Frank GK; Kaye WH; Sahu A; Fernstrom J; McConaha C
Neuropsychopharmacology; 2001 Jun; 24(6):706-9. PubMed ID: 11331150
[TBL] [Abstract][Full Text] [Related]
9. Galanin and α-MSH autoantibodies in cerebrospinal fluid of patients with Alzheimer's disease.
Costa A; Bini P; Hamze-Sinno M; Moglia A; Franciotta D; Sinforiani E; Ravaglia S; Bole-Feysot C; Hökfelt T; Déchelotte P; Fetissov SO
J Neuroimmunol; 2011 Dec; 240-241():114-20. PubMed ID: 22078238
[TBL] [Abstract][Full Text] [Related]
10. Reduced gastrin releasing peptide in cerebrospinal fluid after recovery from bulimia nervosa.
Frank GK; Kaye WH; Ladenheim EE; McConaha C
Appetite; 2001 Aug; 37(1):9-14. PubMed ID: 11562153
[TBL] [Abstract][Full Text] [Related]
11. CSF somatostatin in anorexia nervosa and bulimia: relationship to the hypothalamic pituitary-adrenal cortical axis.
Kaye WH; Rubinow D; Gwirtsman HE; George DT; Jimerson DC; Gold PW
Psychoneuroendocrinology; 1988; 13(3):265-72. PubMed ID: 2900533
[TBL] [Abstract][Full Text] [Related]
12. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
Chan-Palay V
J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
[TBL] [Abstract][Full Text] [Related]
13. Galanin-like immunoreactivity within Ch2 neurons in the vertical limb of the diagonal band of Broca in aging and Alzheimer's disease.
Vogels OJ; Renkawek K; Broere CA; ter Laak HJ; van Workum F
Acta Neuropathol; 1989; 78(1):90-5. PubMed ID: 2472041
[TBL] [Abstract][Full Text] [Related]
14. CSF somatostatin in patients with Alzheimer's disease, older depressed patients, and age-matched control subjects.
Sunderland T; Rubinow DR; Tariot PN; Cohen RM; Newhouse PA; Mellow AM; Mueller EA; Murphy DL
Am J Psychiatry; 1987 Oct; 144(10):1313-6. PubMed ID: 2889377
[TBL] [Abstract][Full Text] [Related]
15. Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease.
Beal MF; MacGarvey U; Swartz KJ
Ann Neurol; 1990 Aug; 28(2):157-61. PubMed ID: 1699471
[TBL] [Abstract][Full Text] [Related]
16. Alterations in cerebrospinal fluid concentrations of somatostatinlike immunoreactivity in neuropsychiatric disorders.
Bissette G; Widerlöv E; Walléus H; Karlsson I; Eklund K; Forsman A; Nemeroff CB
Arch Gen Psychiatry; 1986 Dec; 43(12):1148-51. PubMed ID: 3778111
[TBL] [Abstract][Full Text] [Related]
17. CSF galanin and neuropeptide Y immunoreactivity in progressive supranuclear palsy.
Litvan I; Berrettini WH; Atack JR; Chase TN
Acta Neurol Scand; 1992 Aug; 86(2):204-6. PubMed ID: 1384261
[TBL] [Abstract][Full Text] [Related]
18. Plasma leptin, neuropeptide Y (NPY) and galanin concentrations in bulimia nervosa and in anorexia nervosa.
Baranowska B; Wolinska-Witort E; Wasilewska-Dziubinska E; Roguski K; Chmielowska M
Neuro Endocrinol Lett; 2001 Oct; 22(5):356-8. PubMed ID: 11600878
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid levels of kynurenine pathway metabolites in patients with eating disorders: relation to clinical and biochemical variable.
Demitrack MA; Heyes MP; Altemus M; Pigott TA; Gold PW
Biol Psychiatry; 1995 Apr; 37(8):512-20. PubMed ID: 7542489
[TBL] [Abstract][Full Text] [Related]
20. Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients.
Gerner RH; Yamada T
Brain Res; 1982 Apr; 238(1):298-302. PubMed ID: 6123376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
